Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment

被引:42
作者
Chen, Mengxi [1 ]
Liu, Huan [1 ]
Li, Zhang [2 ]
Ming, Alex Lau [2 ]
Chen, Honglei [1 ,2 ]
机构
[1] Wuhan Univ, Dept Pathol, Zhongnan Hosp, Wuhan 430071, Peoples R China
[2] Wuhan Univ, Sch Basic Med Sci, Dept Pathol, Wuhan 430071, Peoples R China
来源
JOURNAL OF CANCER | 2021年 / 12卷 / 12期
基金
中国国家自然科学基金;
关键词
PKM-2; PD-L1; cancer immunity; metabolism; PYRUVATE-KINASE M2; MITOCHONDRIAL DYNAMICS; CELL METABOLISM; MITOFUSIN; ACTIVATION; GLYCOLYSIS; EXPRESSION; SERINE; TRANSCRIPTION; COACTIVATOR;
D O I
10.7150/jca.54430
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PKM2 is the enzyme that regulates the final rate-limiting step of glycolysis. PKM2 expression can reinforce the utilization of oxygen and synthesis of growth substances in cancer cells by enhancing OXPHOS and the Warburg effect. In cancer immunity, PKM2 can modulate the expression of PD-L1 in M2 macrophage and decrease the amount and activity of CD8(+) T cells. This affects cancer cell killing and immune escape sequentially. How PKM2 regulates PD-L1 expression through immunometabolism is summarized. PKM2 builds a bridge between energy metabolism and cancer immunity. The activator and inhibitor of PKM2 both promote the anti-cancer immune response and inhibit cancer growth and metastasis by regulating the metabolism of cancer cells and immune cells in the tumor microenvironment through HIF-1 alpha/PKM2 pathway. This review focuses on the precise role of PKM2 modulating immunometabolism, providing valuable suggestions for further study in this field.
引用
收藏
页码:3566 / 3574
页数:9
相关论文
共 95 条
  • [1] Pyruvate kinase activators as a therapy target: a patent review 2011-2017
    Adem, Sevki
    Comakli, Veysel
    Uzun, Naim
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (01) : 61 - 68
  • [2] Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
    Albert, ML
    Jegathesan, M
    Darnell, RB
    [J]. NATURE IMMUNOLOGY, 2001, 2 (11) : 1010 - 1017
  • [3] Pyruvate kinase M2: A simple molecule with complex functions
    Alquraishi, Mohammed
    Puckett, Dexter L.
    Alani, Dina S.
    Humidat, Amal S.
    Frankel, Victoria D.
    Donohoe, Dallas R.
    Whelan, Jay
    Bettaieb, Ahmed
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2019, 143 : 176 - 192
  • [4] Pyruvate Kinase M2: A Potential Target for Regulating inflammation
    Alves-Filho, Jose C.
    Palsson-McDermott, Eva M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [5] Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
    Anastasiou, Dimitrios
    Yu, Yimin
    Israelsen, William J.
    Jiang, Jian-Kang
    Boxer, Matthew B.
    Hong, Bum Soo
    Tempel, Wolfram
    Dimov, Svetoslav
    Shen, Min
    Jha, Abhishek
    Yang, Hua
    Mattaini, Katherine R.
    Metallo, Christian M.
    Fiske, Brian P.
    Courtney, Kevin D.
    Malstrom, Scott
    Khan, Tahsin M.
    Kung, Charles
    Skoumbourdis, Amanda P.
    Veith, Henrike
    Southall, Noel
    Walsh, Martin J.
    Brimacombe, Kyle R.
    Leister, William
    Lunt, Sophia Y.
    Johnson, Zachary R.
    Yen, Katharine E.
    Kunii, Kaiko
    Davidson, Shawn M.
    Christofk, Heather R.
    Austin, Christopher P.
    Inglese, James
    Harris, Marian H.
    Asara, John M.
    Stephanopoulos, Gregory
    Salituro, Francesco G.
    Jin, Shengfang
    Dang, Lenny
    Auld, Douglas S.
    Park, Hee-Won
    Cantley, Lewis C.
    Thomas, Craig J.
    Heiden, Matthew G. Vander
    [J]. NATURE CHEMICAL BIOLOGY, 2012, 8 (10) : 839 - 847
  • [6] Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity
    Angiari, Stefano
    Runtsch, Marah C.
    Sutton, Caroline E.
    Palsson-McDermott, Eva M.
    Kelly, Beth
    Rana, Nisha
    Kane, Harry
    Papadopoulou, Gina
    Pearce, Erika L.
    Mills, Kingston H. G.
    O'Neill, Luke A. J.
    [J]. CELL METABOLISM, 2020, 31 (02) : 391 - +
  • [7] Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
    Buck, Michael D.
    O'Sullivan, David
    Geltink, Ramon I. Klein
    Curtis, Jonathan D.
    Chang, Chih-Hao
    Sanin, David E.
    Qiu, Jing
    Kretz, Oliver
    Braas, Daniel
    van der Windt, Gerritje J. W.
    Chen, Qiongyu
    Huang, Stanley Ching-Cheng
    O'Neill, Christina M.
    Edelson, Brian T.
    Pearce, Edward J.
    Sesaki, Hiromi
    Huber, Tobias B.
    Rambold, Angelika S.
    Pearce, Erika L.
    [J]. CELL, 2016, 166 (01) : 63 - 76
  • [8] Serine is a natural ligand and allosteric activator of pyruvate kinase M2
    Chaneton, Barbara
    Hillmann, Petra
    Zheng, Liang
    Martin, Agnes C. L.
    Maddocks, Oliver D. K.
    Chokkathukalam, Achuthanunni
    Coyle, Joseph E.
    Jankevics, Andris
    Holding, Finn P.
    Vousden, Karen H.
    Frezza, Christian
    O'Reilly, Marc
    Gottlieb, Eyal
    [J]. NATURE, 2012, 491 (7424) : 458 - +
  • [9] Dendritic cell development requires histone deacetylase activity
    Chauvistre, Heike
    Kuestermann, Caroline
    Rehage, Nina
    Klisch, Theresa
    Mitzka, Saskia
    Felker, Piritta
    Rose-John, Stefan
    Zenke, Martin
    Sere, Kristin M.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (08) : 2478 - 2488
  • [10] Disruption of fusion results in mitochondrial heterogeneity and dysfunction
    Chen, HC
    Chomyn, A
    Chan, DC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (28) : 26185 - 26192